Alnylam Pharmaceuticals market cap
As of November 2026, Alnylam Pharmaceuticals (ALNY) has a market capitalization of $20.01 B, which makes it #755 among the world’s largest public companies. Over the past year its value changed by −67.2%.
Market cap$20.01 B
World rank#755
1 year−67.2%
Share price$147.82
Market cap over time
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $20.01 B | −62.8% |
| 2025 | $53.83 B | +69.0% |
| 2024 | $31.85 B | +22.9% |
| 2023 | $25.91 B | −19.5% |
| 2022 | $32.17 B | +40.1% |
| 2021 | $22.96 B | +30.5% |
| 2020 | $17.59 B | +12.9% |
| 2019 | $15.59 B | +58.0% |
| 2018 | $9.87 B | −42.6% |
| 2017 | $17.20 B | +239% |
| 2016 | $5.07 B | −60.2% |
| 2015 | $12.74 B | −2.95% |
Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.